Top Markets
#1 Fake World Assets Fake World Assets +11.84%
#2 TENDIES TENDIES +6.51%
#3 Janction Janction +5.07%
#4 GoPlus Security GoPlus Security +4.45%
#5 B3 (Base) B3 (Base) +4.30%
#6 Status Status +4.24%
#7 Everything Everything +3.72%
#8 TronBank TronBank +3.26%
#9 Cross Cross +2.99%
#10 Tutorial Tutorial +2.63%
Coin of the day
Fake World Assets Fake World Assets
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Kineta, Inc. Kineta, Inc.

Kineta, Inc.

KA
Clasificación en acciones #34153
Kineta, Inc. is a clinical-stage biotechnology firm dedicated to developing... Kineta, Inc. is a clinical-stage biotechnology firm dedicated to developing immunotherapies, with a focus on oncology, neuroscience, and biodefense applications. The company engages in partnerships with a variety of entities, including private companies, government bodies, and other industry stakeholders. Among its significant strategic collaborators are Pfizer, Genentech, Wellcome, and Samsung Biologics Co., Ltd. Established in 2007, Kineta, Inc. was previously known as Lecura, Inc. and has its base of operations in Seattle, Washington.
Precio por acción
$0.617
Última sincronización: 2024-10-14
Capitalización bursátil
$6.13M
Cambio (1 día)
0.49%
Cambio (1 año)
0.00%
País
US
Comercio Kineta, Inc. (KA)

Categoría

Healthcare
Ratio P/B de Kineta, Inc. (KA)
Ratio P/B al August 2026 TTM: -0.58
Según los informes financieros más recientes y el precio de las acciones de Kineta, Inc., el ratio P/B actual (TTM) es -0.58. Al final de 2023, el ratio P/B era 13.88.
Historial del ratio P/B de Kineta, Inc. desde 2015 hasta 2026
Ratio P/B al final de cada año
Año Ratio P/B Cambiar
2026 (TTM) -0.58 -6.79%
2024 -0.62 -104.47%
2023 13.88 96.37%
2022 7.07 -463.47%
2021 -1.95 36.18%
2020 -1.43 -198.50%
2019 1.45 71.37%
2018 0.85 -49.33%
2017 1.67 -23.75%
2016 2.19 -92.84%
2015 30.60 0.00%
Ratio P/B de empresas similares o competidoras
Empresa Ratio P/B Diferencia del ratio P/B País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -1,197.40%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -1,180.00%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 3.4612 -698.93%
BE